The effects of vandetanib on paclitaxel tumor distribution and antitumor activity in a xenograft model of human ovarian carcinoma.
This study was designed to determine the effects of vandetanib, a small-molecule receptor tyrosine kinase inhibitor of vascular endothelial growth factor and epidermal growth factor receptor, on paclitaxel (PTX) tumor distribution and antitumor activity in xenograft models of human ovarian carcinoma...
Үндсэн зохиолчид: | Cesca, M, Frapolli, R, Berndt, A, Scarlato, V, Richter, P, Kosmehl, H, D'Incalci, M, Ryan, A, Giavazzi, R |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
2009
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
The Effects of Vandetanib on Paclitaxel Tumor Distribution and Antitumor Activity in a Xenograft Model of Human Ovarian Carcinoma
-н: Marta Cesca, зэрэг
Хэвлэсэн: (2009-11-01) -
Hyaluronic Acid- Paclitaxel: Antitumor Efficacy against CD44(+) Human Ovarian Carcinoma Xenografts
-н: Edmond Auzenne, зэрэг
Хэвлэсэн: (2007-06-01) -
Combination of vandetanib, radiotherapy, and irinotecan in the LoVo human colorectal cancer xenograft model.
-н: Wachsberger, P, зэрэг
Хэвлэсэн: (2009) -
Determination of paclitaxel distribution in solid tumors by nano-particle assisted laser desorption ionization mass spectrometry imaging.
-н: Lavinia Morosi, зэрэг
Хэвлэсэн: (2013-01-01) -
Vandetanib inhibits growth of adenoid cystic carcinoma in an orthotopic nude mouse model.
-н: Choi, S, зэрэг
Хэвлэсэн: (2008)